Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A GOLDMAN

Showing results (11-20 of 894) with videos related to

Pageof 90
Sort By:
Clinical Therapeutics|January 23, 1999
Limitations and strengths of spontaneous reports dataS A Goldman
The Journal of Clinical Investigation|August 22, 2017
Patience pays in spinal repairSteven A Goldman
Drug Safety|July 31, 2016
Causality Assessment in Premarketing Drug Clinical Trials: Regulatory Evolution in the USA and Ongoing ConcernsStephen A Goldman
Drug Safety|May 25, 2004
Communication of medical product risk: how effective is effective enough?Stephen A Goldman
Public Health Reports (Washington, D.C. : 1974)|January 1, 1994
The EPIGRAM computer program for analyzing mortality and population data setsD A Goldman
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Connective tissue disease in people exposed to organic chemical solvents: systemic sclerosis (scleroderma) in dry cleaning plant and aircraft industry workersJ A Goldman
Southern Medical Journal|October 1, 1991
Hypermobility and deconditioning: important links to fibromyalgia/fibrositisJ A Goldman
Clinical Pharmacology and Therapeutics|August 24, 2007
Disease targets and strategies for the therapeutic modulation of endogenous neural stem and progenitor cellsS A Goldman
Cell Stem Cell|February 6, 2016
Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful ThinkingSteven A Goldman
Science (New York, N.Y.)|March 19, 2026
Genes enter the garden of good and evil<b>Original Sin: On the Genetics of Vice, the Problem of Blame, and the Future of Forgiveness</b> <i>Kathryn Paige Harden</i> Random House, 2026. 320 ppMichael A Goldman
Pageof 90

Showing results (11-20 of 894) with videos related to

Sort By:
Pageof 90
Clinical Therapeutics|January 23, 1999
Limitations and strengths of spontaneous reports dataS A Goldman
The Journal of Clinical Investigation|August 22, 2017
Patience pays in spinal repairSteven A Goldman
Drug Safety|July 31, 2016
Causality Assessment in Premarketing Drug Clinical Trials: Regulatory Evolution in the USA and Ongoing ConcernsStephen A Goldman
Drug Safety|May 25, 2004
Communication of medical product risk: how effective is effective enough?Stephen A Goldman
Public Health Reports (Washington, D.C. : 1974)|January 1, 1994
The EPIGRAM computer program for analyzing mortality and population data setsD A Goldman
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Connective tissue disease in people exposed to organic chemical solvents: systemic sclerosis (scleroderma) in dry cleaning plant and aircraft industry workersJ A Goldman
Southern Medical Journal|October 1, 1991
Hypermobility and deconditioning: important links to fibromyalgia/fibrositisJ A Goldman
Clinical Pharmacology and Therapeutics|August 24, 2007
Disease targets and strategies for the therapeutic modulation of endogenous neural stem and progenitor cellsS A Goldman
Cell Stem Cell|February 6, 2016
Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful ThinkingSteven A Goldman
Science (New York, N.Y.)|March 19, 2026
Genes enter the garden of good and evil<b>Original Sin: On the Genetics of Vice, the Problem of Blame, and the Future of Forgiveness</b> <i>Kathryn Paige Harden</i> Random House, 2026. 320 ppMichael A Goldman
Pageof 90